Skip to main content

Advertisement

Table 2 PFN2 protein expression during cancer progression by IHC analysis in Han population

From: PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Cancer progression Immunostaining P value
Low (%) High (%)
Normal esophageal epithelium 124 (91.9) 11 (8.1) : P < 0.001*; : P < 0.001*
Low grade intraepithelial neoplasia 31 (59.6) 21 (40.4) : P < 0.001*; : P < 0.001*
High grade intraepithelial neoplasia 3 (9.0) 30 (91.0) : P = 0.241
ESCC 33 (17.2) 159 (82.8) : P < 0.001*
  1. * P < 0.05, as determined by Pearson’s χ2 test